These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency. Laemmle A; Poms M; Hsu B; Borsuk M; Rüfenacht V; Robinson J; Sadowski MC; Nuoffer JM; Häberle J; Willenbring H Hepatology; 2022 Sep; 76(3):646-659. PubMed ID: 34786702 [TBL] [Abstract][Full Text] [Related]
3. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency. Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review. Kido J; Sugawara K; Sawada T; Matsumoto S; Nakamura K Front Genet; 2022; 13():952467. PubMed ID: 36303552 [TBL] [Abstract][Full Text] [Related]
5. Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With Nguyen HH; Khanh Nguyen N; Dung Vu C; Thu Huong Nguyen T; Nguyen NL Front Pediatr; 2020; 8():321. PubMed ID: 32793520 [No Abstract] [Full Text] [Related]
6. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency. Sugahara G; Yamasaki C; Yanagi A; Furukawa S; Ogawa Y; Fukuda A; Enosawa S; Umezawa A; Ishida Y; Tateno C J Inherit Metab Dis; 2021 May; 44(3):618-628. PubMed ID: 33336822 [TBL] [Abstract][Full Text] [Related]
7. Generation of a human induced pluripotent stem cell line (SDQLCHi036-A) from a patient with ornithine transcarbamylase deficiency carrying a deletion involving 3-9 exons of OTC gene. Guan J; Yan B; Zhang H; Liu C; Li Y; Yang X; Li Z; Gai Z; Liu Y Stem Cell Res; 2021 Apr; 52():102220. PubMed ID: 33550136 [TBL] [Abstract][Full Text] [Related]
8. Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential. Arranz JA; Riudor E; Marco-Marín C; Rubio V J Inherit Metab Dis; 2007 Apr; 30(2):217-26. PubMed ID: 17334707 [TBL] [Abstract][Full Text] [Related]
9. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency. Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058 [TBL] [Abstract][Full Text] [Related]
10. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency. Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473 [TBL] [Abstract][Full Text] [Related]
11. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells. Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397 [TBL] [Abstract][Full Text] [Related]
12. Computational pipeline to identify and characterize functional mutations in ornithine transcarbamylase deficiency. Magesh R; George Priya Doss C 3 Biotech; 2014 Dec; 4(6):621-634. PubMed ID: 28324312 [TBL] [Abstract][Full Text] [Related]
13. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors. Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735 [TBL] [Abstract][Full Text] [Related]
14. An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective Balestra D; Ferrarese M; Lombardi S; Ziliotto N; Branchini A; Petersen N; Bosma P; Pinotti M; van de Graaf SFJ Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228018 [No Abstract] [Full Text] [Related]
15. The phenotypic and mutational spectrum of Thai female patients with ornithine transcarbamylase deficiency. Chongsrisawat V; Damrongphol P; Ittiwut C; Ittiwut R; Suphapeetiporn K; Shotelersuk V Gene; 2018 Dec; 679():377-381. PubMed ID: 30223008 [TBL] [Abstract][Full Text] [Related]
16. Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding. Trivedi M; Zafar S; Spalding MJ; Jonnalagadda S J Clin Gastroenterol; 2001 Apr; 32(4):340-3. PubMed ID: 11276280 [TBL] [Abstract][Full Text] [Related]
17. A serendipitous journey to a promoter variant: The c.-106C>A variant and its role in late-onset ornithine transcarbamylase deficiency. Hertzog A; Selvanathan A; Halligan R; Fazio T; de Jong G; Bratkovic D; Bhattacharya K; Tolun AA; Bennetts B; Fisk K JIMD Rep; 2022 Jul; 63(4):271-275. PubMed ID: 35822098 [TBL] [Abstract][Full Text] [Related]
18. Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions. Su S; Di Poto C; Kroemer AH; Cui W; Roy R; Liu X; Ressom HW Exp Cell Res; 2019 Nov; 384(1):111621. PubMed ID: 31513782 [TBL] [Abstract][Full Text] [Related]